Merck & Co., Inc. (NYSE:MRK) Barclays 26th Annual Global Healthcare Conference March 12, 2024 3:05 PM ET Company Participants Jannie Oosthuizen - President, Human Health U.S. Peter Dannenbaum - Vice President, Investor Relations Conference Call Participants Carter Gould - Barclays Carter Gould Good afternoon and welcome to Day One of the Barclays Global Healthcare Conference. My name is Carter Gould, covering U.S. Biopharma. I'm pleased to welcome Merck to the stage. Merck is one of our top picks to start t ...

Editas Medicine, Inc. (NASDAQ:EDIT) Leerink Partners Global Biopharma Conference March 12, 2024 10:40 AM ET Company Participants Gilmore O'Neill - CEO Erick Lucera - Conference Call Participants Mani Foroohar - Leerink Mani Foroohar Good morning, everyone. Welcome back to the 2024 Global Biopharma Conference, Inaugural Miami Conference. So welcome everybody down. I am Mani Foroohar, Senior Analyst Genetic Medicines. And I'm very fortunate to be hosting the team from Editas Medicine. How are you doing? Gilm ...

AT&T Inc. (NYSE:T) Deutsche Bank's 32 Annual Media, Internet & Telecom Conference March 12, 2024 1:00 PM ET Company Participants Pascal Desroches - Chief Financial Officer Conference Call Participants Bryan Kraft - Deutsche Bank Bryan Kraft Okay. Welcome, everyone. Welcome back again. I'm excited to introduce our next guest on the stage here. Pascal Desroches, the Chief Financial Officer of AT&T. Pascal, welcome. Pascal Desroches Hey, it's a pleasure to be here. Hello, everybody. Maybe before I forget, I'm ...

Southwest Airlines Co. (NYSE:LUV) J.P. Morgan 2024 Industrials Conference March 12, 2024 10:00 AM ET Company Participants Tammy Romo - Executive Vice President & Chief Financial Officer Bob Jordan - President & Chief Executive Officer Conference Call Participants Jamie Baker - JPMorgan Mark Streeter - JPMorgan Jamie Baker All right folks. Moving right along. I am very pleased to turn the spotlight at this point to Southwest Airlines. I just saw Bob speak at ISTAT last week. So I certainly have an idea of so ...

Johnson & Johnson (NYSE:JNJ) Leerink Partners Global Biopharma Conference March 12, 2024 1:00 PM ET Company Participants Joe Wolk - Chief Financial Officer Raychel Kruper - Senior Director of Investor Relations Conference Call Participants David Risinger - Leerink Partners David Risinger Okay. So, we're going to get started here. Sorry, we're starting two minutes late. My apologies. So, my name is Dave Risinger. If you don't know me, I cover diversified biopharmaceuticals for Leerink Partners. And it's very ...

Sanofi (NASDAQ:SNY) Leerink Partners Global Biopharma Conference March 12, 2024 10:40 AM ET Company Participants Naimish Patel - Global Head of Development for Immunology and Inflammation Shaju Backer - Global Head of Immunology Franchise Conference Call Participants Dave Risinger - Leerink Partners Dave Risinger All right. Good morning, everyone. So my name is Dave Risinger, I cover Diversified Biopharmaceuticals for Leerink Partners, and it’s very much my pleasure to welcome you to the session with Sanofi ...

Pfizer Inc. (NYSE:PFE) Leerink Partners Global Biopharma Conference 2024 Call March 12, 2024 8:00 AM ET Company Participants Ronen Tamir - Vice President, Investor Relations Mikael Dolsten - Chief Scientific Officer & President, Pfizer Research and Development Conference Call Participants David Risinger - Leerink Partners David Risinger Good morning, everybody. So it's very much my pleasure to start off the day today with Pfizer's Head of R&D, Mikael Dolsten. It's very much my pleasure to welcome him. And R ...

American Airlines Group Inc. (NASDAQ:AAL) J.P. Morgan 2024 Industrials Conference Call March 12, 2024 9:15 AM ET Company Participants Robert Isom - Chief Executive Officer Devon May - Chief Financial Officer Conference Call Participants Jamie Baker - JPMorgan Mark Streeter - JPMorgan Jamie Baker All right, folks, moving right along. For any of you that were in the room for the United presentation, I was right, Mike Leskinen is the most recently seated CFO in the U.S. So, I stand by what I thought for a mome ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Barclays 26th Annual Global Healthcare Conference Transcript March 12, 2024 11:15 AM ET Executives Chris Fenimore - Chief Financial Officer Ryan Crowe - Vice President, Investor Relations Analysts Carter Gould - Barclays Carter Gould Great. All right. Good morning. And welcome to the Barclays Global Healthcare Conference. My name is Carter Gould covering large-cap biopharma here at Barclays. Welcome, everyone. I’m pleased to welcome Regeneron Pharmaceuticals to ...

Verizon Communications Inc. (NYSE:VZ) Deutsche Bank's 32 Annual Media, Internet & Telecom Conference March 12, 2024 8:00 AM ET Company Participants Sowmyanarayan Sampath - CEO, Verizon Consumer Unit Conference Call Participants Bryan Kraft - Deutsche Bank Bryan Kraft Okay. Good morning, everyone. Thanks for joining us this morning for breakfast, and for our first fireside chat of the day. I'd like to welcome everyone again today to the conference. And just again express thanks to -- for your support come in ...